Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
2005 1
2006 1
2007 1
2009 1
2010 2
2011 3
2012 2
2013 2
2014 4
2016 1
2018 1
2019 1
2020 5
2021 6
2022 4
2023 3
2024 3
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial.
Sojo-Dorado J, López-Hernández I, Rosso-Fernandez C, Morales IM, Palacios-Baena ZR, Hernández-Torres A, Merino de Lucas E, Escolà-Vergé L, Bereciartua E, García-Vázquez E, Pintado V, Boix-Palop L, Natera-Kindelán C, Sorlí L, Borrell N, Giner-Oncina L, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martínez-Alvarez RM, Dueñas CJ, Calvo-Montes J, Silva JT, Cárdenes MA, Lecuona M, Pomar V, Valiente de Santis L, Yagüe-Guirao G, Lobo-Acosta MA, Merino-Bohórquez V, Pascual A, Rodríguez-Baño J; REIPI-GEIRAS-FOREST group. Sojo-Dorado J, et al. Among authors: merino de lucas e. JAMA Netw Open. 2022 Jan 4;5(1):e2137277. doi: 10.1001/jamanetworkopen.2021.37277. JAMA Netw Open. 2022. PMID: 35024838 Free PMC article. Clinical Trial.
Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial.
Sojo-Dorado J, López-Hernández I, Hernández-Torres A, Retamar-Gentil P, Merino de Lucas E, Escolà-Vergé L, Bereciartua E, García-Vázquez E, Pintado V, Boix-Palop L, Natera-Kindelán C, Sorlí L, Borrell N, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martínez-Álvarez RM, Dueñas CJ, Calvo-Montes J, Lecuona M, Pomar V, Borreguero I, Palomo-Jiménez V, Docobo-Pérez F, Pascual Á, Rodríguez-Baño J. Sojo-Dorado J, et al. Among authors: merino de lucas e. J Antimicrob Chemother. 2023 Jul 5;78(7):1658-1666. doi: 10.1093/jac/dkad147. J Antimicrob Chemother. 2023. PMID: 37260299 Free PMC article. Clinical Trial.
Clinical characteristics, predisposing factors and outcomes for Enterococcus faecalis versus Enterococcus faecium bloodstream infections: a prospective multicentre cohort study.
Scharloo F, Cogliati Dezza F, López-Hernández I, Martínez Pérez-Crespo PM, Goikoetxea Aguirre AJ, Pérez-Rodríguez MT, Fernandez-Suarez J, León Jiménez E, Morán Rodríguez MÁ, Fernández-Natal I, Reguera Iglesias JM, Natera Kindelán C, Fariñas Álvares MC, Boix-Palop L, Lopez-Cortes LE, Rodríguez-Baño J; PROBAC/GEIRAS-SEIMC/SAMICEI group. Scharloo F, et al. Eur J Clin Microbiol Infect Dis. 2024 Oct;43(10):2011-2022. doi: 10.1007/s10096-024-04917-5. Epub 2024 Aug 8. Eur J Clin Microbiol Infect Dis. 2024. PMID: 39112668 Free PMC article.
COVID-19 clinical phenotypes in vaccinated and nonvaccinated solid organ transplant recipients: a multicenter validation study.
Infante-Domínguez C, Salto-Alejandre S, Álvarez-Marín R, Sabé N, Ramos-Martínez A, Moreno A, Ferreira de Moraes K, Palacios-Baena ZR, Muñoz P, Fernández-Ruiz M, Blanes M, Fariñas C, Vidal E, Merino de Lucas E, Halpern M, Hernández-Gallego R, Bassetti M, Mularoni A, Gutiérrez-Dalmau A, Rinaldi M, Jiménez-Jorge S, Bodro M, Aranha-Camargo LF, Valerio M, Sánchez-Céspedes J, Gutiérrez-Gutiérrez B, Giannella M, Rodríguez-Baño J, Pachón J, Cordero E; COVIDSOT, ORCHESTRA Working Teams. Infante-Domínguez C, et al. Among authors: merino de lucas e. Sci Rep. 2024 Dec 3;14(1):30021. doi: 10.1038/s41598-024-81099-2. Sci Rep. 2024. PMID: 39622951 Free PMC article.
SARS-CoV-2 or Pnuemocystis jirovecii? A case report.
González Moyano AB, Medina Ramos L, Del Cañizo Moreira M, Merino de Lucas E, González Lorenzo M, Esteban García-Fontecha M. González Moyano AB, et al. Among authors: merino de lucas e. Med Intensiva (Engl Ed). 2021 Mar;45(2):124-126. doi: 10.1016/j.medin.2020.07.007. Epub 2020 Jul 31. Med Intensiva (Engl Ed). 2021. PMID: 32854989 Free PMC article. No abstract available.
[SARS-CoV-2 or Pnuemocystis jirovecii? A case report].
González Moyano AB, Medina Ramos L, Del Cañizo Moreira M, Merino de Lucas E, González Lorenzo M, Esteban García-Fontecha M. González Moyano AB, et al. Among authors: merino de lucas e. Med Intensiva. 2021 Mar;45(2):124-126. doi: 10.1016/j.medin.2020.07.007. Epub 2020 Jul 31. Med Intensiva. 2021. PMID: 38620804 Free PMC article. Spanish. No abstract available.
Application of validated severity scores for pneumonia caused by SARS-CoV-2.
Esteban Ronda V, Ruiz Alcaraz S, Ruiz Torregrosa P, Giménez Suau M, Nofuentes Pérez E, León Ramírez JM, Andrés M, Moreno-Pérez Ó, Candela Blanes A, Gil Carbonell J, Merino de Lucas E. Esteban Ronda V, et al. Among authors: merino de lucas e. Med Clin (Engl Ed). 2021 Aug 13;157(3):99-105. doi: 10.1016/j.medcle.2021.01.011. Epub 2021 Jun 30. Med Clin (Engl Ed). 2021. PMID: 34226877 Free PMC article.
Effectiveness of the systematic use of antimicrobial filters in the water taps of critical care units for the prevention of healthcare-associated infections with Pseudomonas aeruginosa.
Chico-Sánchez P, Gras-Valentí P, Algado-Sellés N, Jiménez-Sepúlveda N, Rodríguez-Díaz JC, Merino-deLucas E, Galiana-Ivars M, Fuster-Pérez M, Cartagena-Llopis L, Balboa-Esteve S, Cánovas-Jávega S, Esclapez-Martínez A, Monerris-Palmer M, Cerezo-Milán P, Sánchez-Payá J, Ronda-Pérez E. Chico-Sánchez P, et al. Am J Infect Control. 2022 Apr;50(4):435-439. doi: 10.1016/j.ajic.2021.10.029. Am J Infect Control. 2022. PMID: 35369937
Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study.
Escudero-Sanchez R, Muriel García A, García Fernández S, Valencia Alijo A, Tasias Pitarch M, Merino De Lucas E, Gutierrez Rojas A, Ramos Martínez A, Salavert Lletí M, Giner L, Ruíz Ruigomez M, García Basas L, Fernández Fradejas J, Olmedo Sampedrio M, Cano Yuste A, Díaz Pollán B, Rodríguez Hernández MJ, Martín Segarra O, Sáez Bejar C, Armiñanzas Castillo C, Gutiérrez B, Rodríguez-Pardo D, De La Torre Cisneros J, López Medrano F, Cobo Reinoso J. Escudero-Sanchez R, et al. Among authors: merino de lucas e. J Antimicrob Chemother. 2022 Jun 29;77(7):1996-2002. doi: 10.1093/jac/dkac106. J Antimicrob Chemother. 2022. PMID: 35403189
Application of validated severity scores for pneumonia caused by SARS-CoV-2.
Esteban Ronda V, Ruiz Alcaraz S, Ruiz Torregrosa P, Giménez Suau M, Nofuentes Pérez E, León Ramírez JM, Andrés M, Moreno-Pérez Ó, Candela Blanes A, Gil Carbonell J, Merino de Lucas E. Esteban Ronda V, et al. Among authors: merino de lucas e. Med Clin (Barc). 2021 Aug 13;157(3):99-105. doi: 10.1016/j.medcli.2021.01.002. Epub 2021 Jan 28. Med Clin (Barc). 2021. PMID: 33637335 Free PMC article. English, Spanish.
38 results